Literature DB >> 30746169

VISTA/PD-1H: a potential target for non-small cell lung cancer immunotherapy.

Juan-Manuel Hernandez-Martinez1,2, Edgar Vergara1, Zyanya Lucia Zatarain-Barrón1, Feliciano Barrón-Barrón1, Oscar Arrieta1.   

Abstract

Entities:  

Year:  2018        PMID： 30746169      PMCID： PMC6344701          DOI： 10.21037/jtd.2018.11.39

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  3 in total

Review 1.  IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy.

Authors:  Xi-Yang Tang; Yan-Lu Xiong; Xian-Gui Shi; Ya-Bo Zhao; An-Ping Shi; Kai-Fu Zheng; Yu-Jian Liu; Tao Jiang; Nan Ma; Jin-Bo Zhao
Journal:  Biomark Res       Date:  2022-07-13

Review 2.  VISTA: an immune regulatory protein checking tumor and immune cells in cancer immunotherapy.

Authors:  Xing Huang; Xiaozhen Zhang; Enliang Li; Gang Zhang; Xun Wang; Tianyu Tang; Xueli Bai; Tingbo Liang
Journal:  J Hematol Oncol       Date:  2020-06-29       Impact factor: 17.388

3.  TNF-α-Secreting Lung Tumor-Infiltrated Monocytes Play a Pivotal Role During Anti-PD-L1 Immunotherapy.

Authors:  Kirsten De Ridder; Hanne Locy; Elisa Piccioni; Miren Ibarra Zuazo; Robin Maximilian Awad; Stefaan Verhulst; Mathias Van Bulck; Yannick De Vlaeminck; Quentin Lecocq; Eva Reijmen; Wout De Mey; Lien De Beck; Thomas Ertveldt; Isabel Pintelon; Jean-Pierre Timmermans; David Escors; Marleen Keyaerts; Karine Breckpot; Cleo Goyvaerts
Journal:  Front Immunol       Date:  2022-04-14       Impact factor: 8.786
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.